Exelead
Indianapolis
About Exelead
Exelead is a dynamic platform that develops and produces liposomal and LNP drug product formulations. Founded in 2017, the company specializes in manufacturing lipid nanoparticle, liposome, and pegylation formulations. Exelead is a wholly-owned subsidiary of Essetifin SpA in Rome, Italy’a privately owned pharmaceutical company specializing in Rare Diseases and Orphan Drugs.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Website: exeleadbiopharma.com
- Phone: +1 317-347-2800
Social Profiles
Canonical: https://fsome.com/organization/exelead-2783378 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.